Author

E. Afyounian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:cell type annotation· 2 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

J. Kesseli· 3 shared M. Nykter· 3 shared A. Urbanucci· 2 shared K. J. Rautajoki· 2 shared L. Latonen· 2 shared T. L. J. Tammela· 2 shared T. Visakorpi· 2 shared A. Erickson· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Kesseli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunosuppression in the prostate tumor microenvironment is tied to androgen deprivation therapy-resistant club-like cells

A. Kiviaho, S. K. Eerola, H. M. L. Kallio, M. K. Andersen, X. Spotbeen, A. Giesen, C. T. A. Parker, S. Taavitsainen, O. Hantula, M. Marttinen, I. Hermelo, M. Ismail, E. Midtbust, M. Wess, W. Devlies, , M. Nykter

The paper identifies club-like cells in the prostate tumor microenvironment that contribute to androgen deprivation therapy resistance through immune suppression.

bioRxiv · Mar 25, 2024 · PreprintCancer Biology

Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors

M. Pekkarinen, K. Nordfors, J. Uusi-Makela, V. Kytola, M. Rauhala, H. Urhonen, S. Hayrynen, E. Afyounian, O. Yli-Harja, W. Zhang, P. Helen, O. Lohi, H. Haapasalo, J. Haapasalo, M. Nykter, , K. J. Rautajoki

This study identifies aberrant DNA methylation patterns in AT/RTs that disrupt neural development and contribute to tumor malignancy.

bioRxiv · Mar 14, 2022Cancer Biology

Chromatin accessibility analysis uncovers regulatory element landscape in prostate cancer progression

J. Uusi-Mäkelä, E. Afyounian, F. Tabaro, T. Häkkinen, A. Lussana, A. Shcherban, M. Annala, R. Nurminen, K. Kivinummi, T. L. J. Tammela, A. Urbanucci, L. Latonen, J. Kesseli, K. J. Granberg, T. Visakorpi, M. Nykter

The paper analyzes chromatin accessibility in prostate cancer stages to identify regulatory elements and their role in gene expression changes during disease progression.

bioRxiv · Sep 8, 2020 · PreprintCancer Biology